Operating Lease, Right-of-Use Asset of Emmaus Life Sciences, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Emmaus Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Emmaus Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $799,000, a 54% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $799,000 -$920,000 -54% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $830,000 -$1,073,000 -56% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,331,000 -$751,000 -36% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,530,000 -$807,000 -35% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $1,719,000 -$791,000 -32% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $1,903,000 -$682,000 -26% 30 Jun 2024 10-Q 10 Sep 2024 2024 Q2
Q1 2024 $2,082,000 -$564,000 -21% 31 Mar 2024 10-Q 10 Sep 2024 2024 Q1
Q4 2023 $2,337,000 -$462,000 -17% 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q3 2023 $2,510,000 -$434,000 -15% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,585,000 -$500,000 -16% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,646,000 -$672,000 -20% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,799,000 -$686,000 -20% 31 Dec 2022 10-K 03 Jul 2024 2023 FY
Q3 2022 $2,944,000 -$698,000 -19% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $3,085,000 -$711,000 -19% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $3,318,000 -$629,000 -16% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $3,485,000 -$587,000 -14% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $3,642,000 -$503,000 -12% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $3,796,000 -$487,000 -11% 30 Jun 2021 10-Q 01 Sep 2021 2021 Q2
Q1 2021 $3,947,000 -$397,000 -9.1% 31 Mar 2021 10-Q 01 Sep 2021 2021 Q1
Q4 2020 $4,072,000 -$402,000 -9% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $4,145,000 +$27,000 +0.66% 30 Sep 2020 10-Q 26 Aug 2021 2020 Q3
Q2 2020 $4,283,000 -$2,000 -0.05% 30 Jun 2020 10-Q 26 Aug 2021 2020 Q2
Q1 2020 $4,344,000 +$1,506,000 +53% 31 Mar 2020 10-Q 26 Aug 2021 2020 Q1
Q4 2019 $4,474,000 31 Dec 2019 10-Q 26 Aug 2021 2020 Q2
Q3 2019 $4,118,000 30 Sep 2019 10-K 25 Jan 2021 2019 FY
Q2 2019 $4,285,000 30 Jun 2019 10-Q 26 Aug 2021 2020 Q2
Q1 2019 $2,838,000 31 Mar 2019 10-Q 26 Aug 2021 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.